This site is intended for Healthcare professionals only.

USFDA completes inspection of Natco’s mekaguda API facility


USFDA completes inspection of Natco’s mekaguda API facility

Natco Pharma Limited has announced the successful completion of regulatory inspection from the United States Food and Drug Administration (USFDA) for its Active Pharmaceutical Ingredient (API) facility in Mekaguda Village, near Hyderabad, India.

The inspection was conducted during the period 12th February 2018 to 16th February 2018.

The regulatory audit resulted in zero observations (no form 483 issued).



Source: Press Release
0 comment(s) on USFDA completes inspection of Natco’s mekaguda API facility

Share your Opinion Disclaimer

Sort by: Newest | Oldest | Most Voted